Cornerstone Planning Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51
| Closed | -$5.39K | – | 1630 |
|
|
2025
Q1 | $5.39K | Sell |
51
-3
| -6% | -$317 | ﹤0.01% | 710 |
|
|
2024
Q4 | $6.33K | Buy |
54
+3
| +6% | +$352 | ﹤0.01% | 531 |
|
|
2024
Q3 | $5.89K | Hold |
51
| – | – | ﹤0.01% | 534 |
|
|
2024
Q2 | $5.01K | Hold |
51
| – | – | ﹤0.01% | 576 |
|
|
2024
Q1 | $3.77K | Hold |
51
| – | – | ﹤0.01% | 564 |
|
|
2023
Q4 | $3.64K | Hold |
51
| – | – | ﹤0.01% | 567 |
|
|
2023
Q3 | $3.06K | Hold |
51
| – | – | ﹤0.01% | 596 |
|
|
2023
Q2 | $3.68K | Buy |
+51
| New | +$3.68K | ﹤0.01% | 1006 |
|
|
2022
Q4 | $3.62K | Buy |
+51
| New | +$3.62K | ﹤0.01% | 1039 |
|